论文部分内容阅读
[目的]鉴于对妊娠合并恶性肿瘤的处理上的不确定性及疑问,通过对妊娠合并恶性肿瘤患者的病例收集和分析,以期获得为寻找妊娠期恶性肿瘤的最佳处理方案提供临床依据。[方法]采用回顾性资料分析方法,收集了某医院1990年1月～2010年12月收治的在妊娠期被诊断为合并了恶性肿瘤的病例9例。同时随机抽出100例同期在院分娩没有妊娠合并症的正常产妇做为对照组。[结果]妊娠合并恶性肿瘤的院内检出率为0.318‰。[结论]妊娠合并恶性肿瘤发病率、生存率低,对母儿影响大,终止妊娠并不能延长生存时间。妊娠合并恶性肿瘤的孕期处理应在遵循肿瘤治疗原则的基础上根据肿瘤分期、妊娠孕周、患者意愿等制定出一个个性化的处理方案。
[Objective] In view of the uncertainty and doubt about the handling of malignant tumors in pregnancy, we collected and analyzed the cases of patients with malignant tumors in pregnancy in order to provide a clinical basis for finding the best treatment plan for malignant tumors in pregnancy. [Methods] A retrospective data analysis method was used to collect 9 patients who were diagnosed with malignant tumor during pregnancy from January 1990 to December 2010 in a hospital. At the same time, a random sample of 100 cases of normal maternal pregnancy without pregnancy complications in the same period as a control group. [Results] The detection rate of pregnant women with malignant tumors was 0.318 ‰. [Conclusion] The incidence of malignant tumors with pregnancy, low survival rate, affecting the mother and child, termination of pregnancy can not extend the survival time. Pregnancy with malignant tumor pregnancy treatment should follow the principle of tumor treatment based on the tumor staging, gestational gestational age, the patient’s wishes to develop a personalized treatment options.